Stay updated on Cladribine, Idarubicin & Cytarabine for AML Clinical Trial

Sign up to get notified when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New revision v3.4.2 was added to the history; revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T00:35:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.
    Difference
    0.1%
    Check dated 2026-02-04T23:29:35.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Glossary is now shown and changes in the study record are color-coded (green for additions, red for deletions). The revision label was updated from v3.3.4 to v3.4.0, and the No FEAR Act data entry was removed.
    Difference
    0.8%
    Check dated 2026-01-28T20:28:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Record History now includes a new revision (v3.3.4) and removal of the previous revision (v3.3.3), which are minor internal versioning updates with no user-visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:06:57.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The latest version adds a Study Status entry and Revision: v3.3.3 dated 2025-12-17. The previous HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed on 2025-06-10.
    Difference
    0.5%
    Check dated 2025-12-23T22:41:19.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.3.2; the previous v3.2.0 label was removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:43.000Z thumbnail image

Stay in the know with updates to Cladribine, Idarubicin & Cytarabine for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.